Document Detail


Acquired factor VIII inhibitor presenting as a tongue hematoma.
MedLine Citation:
PMID:  15093846     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acquired hemophilia is a rare disorder that has potentially disastrous consequences if not recognized and treated in the setting of acute hemorrhage. We report a case of undiagnosed acquired hemophilia due to factor VIII inhibitor in which a tongue hematoma was the chief manifestation. Diagnosis, acute management, and long-term therapeutic options are reviewed.
Authors:
Catherine M Wendell; Marc A Bellazzini; David S Howes
Related Documents :
23042846 - The history of dengue outbreaks in the americas.
23597216 - Natal and neonatal teeth: a systematic review of prevalence and management.
3513296 - The value of routine sonography in clinically suspected acute cholecystitis.
11873106 - Constrictive pericarditis in chronic ulcerative colitis.
498836 - Primary pulmonary hypertension. responses to indomethacin, terbutaline, and isoproterenol.
10761356 - Case study: bipolar disorder after head injury.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of emergency medicine     Volume:  26     ISSN:  0736-4679     ISO Abbreviation:  J Emerg Med     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-04-19     Completed Date:  2004-07-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8412174     Medline TA:  J Emerg Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  411-4     Citation Subset:  IM    
Affiliation:
Section of Emergency Medicine, University of Chicago, Chicago, Illinois, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Blood Coagulation Factors / therapeutic use
Factor VIII / antagonists & inhibitors*
Female
Hematoma / etiology*
Hemophilia A / complications*,  drug therapy
Humans
Partial Thromboplastin Time
Tongue Diseases / etiology*
Chemical
Reg. No./Substance:
0/Blood Coagulation Factors; 37224-63-8/prothrombin complex concentrates; 9001-27-8/Factor VIII

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antipyretic effectiveness of intravenous ketorolac tromethamine.
Next Document:  SARS and its impact on current and future Emergency Department operations.